Trial Profile
To demonstrate the efficacy of Entecavir in naive and nuc experienced patients with chronic Hepatitis B and Liver cirrhosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2015 New trial record